Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
42 studies found for:    Tardive Dyskinesia
Show Display Options
Rank Status Study
1 Recruiting A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: NBI-98854;   Drug: Placebo
2 Completed NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder
Condition: Tardive Dyskinesia
Interventions: Drug: NBI-98854;   Drug: Placebo
3 Completed Tardive Dyskinesia and Cognitive Function
Conditions: Tardive Dyskinesia;   Neurocognitive Function
Interventions: Drug: amisulpride;   Drug: Olanzapine;   Drug: Conventional antipsychotics
4 Completed Treatment of Tardive Dyskinesia With Galantamine
Condition: Tardive Dyskinesia
Intervention: Drug: Galantamine
5 Completed Extract of Ginkgo Biloba and Tardive Dyskinesia
Conditions: Tardive Dyskinesia;   Schizophrenia
Interventions: Drug: Extract of Ginkgo Biloba (EGb-761 capsules);   Drug: Placebo
6 Completed Melatonin Treatment for Tardive Dyskinesia in Schizophrenia
Condition: Tardive Dyskinesia
Interventions: Drug: Melatonin;   Drug: Placebo
7 Completed Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention: Drug: NBI-98854
8 Unknown  Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Dietary Supplement: Omega-3 fish oil capsules (including DHA);   Dietary Supplement: Placebo
9 Completed Piracetam for Treatment Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention: Drug: piracetam
10 Completed NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: NBI-98854;   Drug: Placebo
11 Terminated Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: Pyridoxal 5'-Phosphate;   Drug: Placebo
12 Completed NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Condition: Tardive Dyskinesia
Interventions: Drug: NBI-98854;   Drug: Placebo
13 Completed Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
Condition: Neuroleptic-Induced Tardive Dyskinesia
Interventions: Drug: risperidone;   Drug: olanzapine
14 Recruiting A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia
Condition: Drug-induced Tardive Dyskinesia
Interventions: Drug: SNC-102;   Drug: Placebo
15 Completed Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia
Condition: Dyskinesia, Medication-induced
Intervention: Drug: Levetiracetam
16 Recruiting D-Serine Treatment For Tardive Dyskinesia
Conditions: Schizophrenia and Schizoaffective Disorder;   Tardive Dyskinesia
Intervention: Dietary Supplement: D-serine
17 Not yet recruiting Reducing Involuntary Movements in Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention: Drug: SD-809
18 Recruiting Aim to Reduce Movements in Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: SD-809;   Drug: Placebo
19 Recruiting Addressing Involuntary Movements in Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention: Drug: SD-809
20 Terminated Sarizotan in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
Condition: Neuroleptic-Induced Tardive Dyskinesia
Intervention: Drug: Sarizotan

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years